These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Initial experience with FK506 (tacrolimus) in pediatric renal transplant recipients. McKee M, Segev D, Wise B, Case B, Neu A, Fivush B, Colombani P. J Pediatr Surg; 1997 May; 32(5):688-90. PubMed ID: 9165452 [Abstract] [Full Text] [Related]
3. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria. Morrissey PE, Gohh R, Shaffer D, Crosson A, Madras PN, Sahyoun AI, Monaco AP. Transplantation; 1997 Mar 27; 63(6):845-8. PubMed ID: 9089224 [Abstract] [Full Text] [Related]
4. Tacrolimus for primary treatment of steroid-resistant hepatic allograft rejection. Millis JM, Woodle ES, Piper JB, Bruce DS, Newell KA, Seaman DS, Baker AL, Hart J, Dasgupta K, Thistlethwaite JR. Transplantation; 1996 May 15; 61(9):1365-9. PubMed ID: 8629298 [Abstract] [Full Text] [Related]
5. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial. Jonas S, Kling N, Bechstein WO, Blumhardt G, Lohmann R, Lobeck H, Neuhaus P. Clin Transplant; 1995 Oct 15; 9(5):406-14. PubMed ID: 8541635 [Abstract] [Full Text] [Related]
6. Management of acute steroid-resistant rejection after liver transplantation. Platz KP, Mueller AR, Zytowski M, Lemmens P, Lobeck H, Neuhaus P. World J Surg; 1996 Oct 15; 20(8):1052-8; discussion 1058-9. PubMed ID: 8798364 [Abstract] [Full Text] [Related]
9. Tacrolimus: a superior agent to OKT3 for treating cases of persistent rejection after intrathoracic transplantation. Meiser BM, Uberfuhr P, Fuchs A, Schulze C, Nollert G, Mair H, Martin S, Pfeiffer M, Reichenspurner H, Kreuzer E, Reichart B. J Heart Lung Transplant; 1997 Aug 15; 16(8):795-800. PubMed ID: 9286771 [Abstract] [Full Text] [Related]
10. OKT3 therapy in addition to tacrolimus is associated with improved long-term function in patients with steroid refractory renal allograft rejection. Patschan D, Kribben A, Pietruck F, Lutz J, Binek M, Philipp T, Heemann U, Witzke O. Nephron Clin Pract; 2006 Aug 15; 103(3):c94-9. PubMed ID: 16534238 [Abstract] [Full Text] [Related]
11. Initial experience with tacrolimus rescue therapy in OKT3 resistant rejection. Herget S, Heemann U, Friedrich J, Kribben A, Wagner K, Philipp T. Clin Nephrol; 1996 May 15; 45(5):352-4. PubMed ID: 8738671 [Abstract] [Full Text] [Related]
12. A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation. Gruessner RW, Burke GW, Stratta R, Sollinger H, Benedetti E, Marsh C, Stock P, Boudreaux JP, Martin M, Drangstveit MB, Sutherland DE, Gruessner A. Transplantation; 1996 Jan 27; 61(2):261-73. PubMed ID: 8600635 [Abstract] [Full Text] [Related]
13. Predicting factors of long-term results of OKT3 therapy for steroid resistant acute rejection following cadaveric renal transplantation. Rostaing L, Chabannier MH, Modesto A, Rouzaud A, Cisterne JM, Tkaczuk J, Durand D. Am J Nephrol; 1999 Jan 27; 19(6):634-40. PubMed ID: 10592356 [Abstract] [Full Text] [Related]
14. Half dose of OKT3 is efficient in treatment of steroid-resistant renal allograft rejection. Midtvedt K, Tafjord AB, Hartmann A, Eide TC, Holdaas H, Nordal KP, Draganov B, Sødal G, Leivestad T, Fauchald P. Transplantation; 1996 Jul 15; 62(1):38-42. PubMed ID: 8693541 [Abstract] [Full Text] [Related]
15. FK 506 in the treatment of steroid- and OKT3-resistant rejection in renal transplant recipients: reduced dosage and anti-infective prophylaxis. Kliem V, Eberhard OK, Oldhafer K, Schlitt HJ, Behrend M, Schaumann D, Pichlmayr R, Koch KM, Brunkhorst R. Transplant Proc; 1996 Dec 15; 28(6):3166-8. PubMed ID: 8962227 [No Abstract] [Full Text] [Related]
16. Rescue therapy with tacrolimus after combined kidney/pancreas and isolated pancreas transplantation in patients with severe cyclosporine nephrotoxicity. Hariharan S, Munda R, Cavallo T, Demmy AM, Schroeder TJ, Alexander JW, First MR. Transplantation; 1996 Apr 27; 61(8):1161-5. PubMed ID: 8610411 [Abstract] [Full Text] [Related]
17. Conversion of renal transplant recipients from cyclosporin to low-dose tacrolimus for refractory rejection. Morris-Stiff G, Talbot D, Balaji V, Baboolal K, Callanan K, Hails J, Moore R, Manas D, Lord R, Jurewicz WA. Transpl Int; 1998 Apr 27; 11 Suppl 1():S78-81. PubMed ID: 9664949 [Abstract] [Full Text] [Related]
18. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation. Woodle ES, Bruce DS, Josephson M, Newell KA, Piper JB, Millis JM, Cronin D, Whitman G, Ruebe M, Thistlethwaite JR. Clin Transplant; 1996 Aug 27; 10(4):323-32. PubMed ID: 8884103 [Abstract] [Full Text] [Related]
19. A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group. Woodle ES, Thistlethwaite JR, Gordon JH, Laskow D, Deierhoi MH, Burdick J, Pirsch JD, Sollinger H, Vincenti F, Burrows L, Schwartz B, Danovitch GM, Wilkinson AH, Shaffer D, Simpson MA, Freeman RB, Rohrer RJ, Mendez R, Aswad S, Munn SR, Wiesner RH, Delmonico FL, Neylan J, Whelchel J. Transplantation; 1996 Sep 15; 62(5):594-9. PubMed ID: 8830821 [Abstract] [Full Text] [Related]
20. Tacrolimus rescue therapy for renal allograft rejection--five-year experience. Jordan ML, Naraghi R, Shapiro R, Smith D, Vivas CA, Scantlebury VP, Gritsch HA, McCauley J, Randhawa P, Demetris AJ, McMichael J, Fung JJ, Starzl TE. Transplantation; 1997 Jan 27; 63(2):223-8. PubMed ID: 9020321 [Abstract] [Full Text] [Related] Page: [Next] [New Search]